Saxenda Weight Loss Injection (Liraglutide)

Saxenda Weight Loss Injection: What It Is

The Saxenda weight loss injection is a once-daily prescription medicine used to support weight loss in adults, as part of a wider calorie-controlled diet and exercise plan. Its active ingredient is liraglutide, a GLP-1 receptor agonist, the same drug class as Wegovy and Ozempic, though liraglutide itself works slightly differently in formulation and dosing frequency.

Liraglutide mimics GLP-1, a natural gut hormone released when you eat, which signals to your brain that you’re full. By extending how long that signal lasts in the body, Saxenda reduces appetite and helps you eat less, making it easier to maintain a calorie deficit. It’s injected subcutaneously, just under the skin of the abdomen, thigh or upper arm, once every day.

Eligibility. UK providers typically prescribe Saxenda (or its generic equivalent) for adults with a BMI of 30 or above, or a BMI of 27-30 with a weight-related health condition such as high blood pressure, type 2 diabetes or sleep apnoea.

Is Saxenda Available in the UK Right Now?

This is the most important question for anyone searching Saxenda injection in UK, and the honest answer is no, not currently. Saxenda is long-term out of stock across every UK prescribing channel, including the NHS and private online doctor services. This isn’t a brand-specific marketing gap; it reflects an actual supply shortage of the branded product.

What has replaced it is Nevolat, a generic version containing the exact same active ingredient (liraglutide) at the same strength, working identically in the body. It’s simply sold under a different name, pricing and packaging, the same relationship as, say, a branded versus generic paracetamol. If you’re specifically trying to access liraglutide treatment in the UK today, Nevolat is the current route.

Saxenda Injection Price: What It Cost When Available

For reference, Saxenda injection price when the branded product was last in stock through UK online pharmacy services was tiered by pack size:

• Single pen pack: around £55 per pen
• 3-pen pack: around £48 per pen (£144 total)
• 5-pen pack: around £46 per pen (£230 total)

Generic Nevolat is currently priced from around £94.97 to £127.00 depending on the provider and pack size, broadly comparable to, or somewhat higher than, Saxenda’s historic pricing, though exact figures vary by pharmacy and change over time.

Saxenda Injection for Sale: What to Actually Do Instead

If you’ve been searching for Saxenda injection for sale, here’s what that search should actually lead you to right now:

1. Ask about generic liraglutide (Nevolat) through a registered UK online doctor service or your GP, it’s the same medicine, currently in stock, and works identically.
2. Complete a genuine clinical consultation. Any legitimate UK provider requires a medical questionnaire, and often photographic evidence of current weight, before prescribing, regardless of whether you’re asking for Saxenda or Nevolat by name.
3. Be very cautious of any site claiming to sell Saxenda directly, with no consultation, while it’s confirmed out of stock nationwide. That’s a strong signal of a non-compliant or potentially counterfeit seller, not a genuine supply source.
4. Consider whether a different GLP-1 option suits you better. Since you’re already comparing treatments, it’s worth knowing Mounjaro (tirzepatide, weekly injection) and Wegovy (semaglutide, weekly injection) are both currently available and, for many people, show somewhat higher average weight-loss results than liraglutide-based treatment.

How Effective Is Saxenda (Liraglutide)?

According to data from the UK product licence (EMC), after 56 weeks of treatment at the maintenance dose:

• Just over half of people (50.7%) lost at least 5% of their starting body weight
• 27.4% lost more than 10% of their starting weight
• On average, people lost around 6kg, compared to 0.2kg on placebo, when combined with diet and exercise

Dosing starts low and increases gradually over the first five weeks to a maintenance dose of 3mg daily, a slower, more gradual titration than the weekly-injection alternatives, which some people find easier to tolerate.

Common Side Effects

The most frequently reported side effects are gastrointestinal: nausea, vomiting, constipation and diarrhoea, usually most noticeable early in treatment and easing as the body adjusts. Less common effects include injection-site reactions, bloating, dry mouth, heartburn and fatigue. Seek emergency help for signs of an allergic reaction (facial or throat swelling, breathing difficulty, rapid heartbeat) or severe abdominal pain, which can signal pancreatitis.

Who Shouldn’t Use Liraglutide-Based Treatment

Generally not suitable for anyone who is pregnant, planning pregnancy, or breastfeeding, or aged over 75. Tell your prescriber if you have heart failure, liver or kidney problems, inflammatory bowel disease, gastroparesis, pancreatitis, gallbladder issues, or thyroid disease, including any history of thyroid tumours, since these all need to be weighed against treatment before a prescription is issued.

Frequently Asked Questions

Can I still get Saxenda in the UK?
Not currently. Saxenda is long-term out of stock nationwide. Generic liraglutide (Nevolat) is available instead and works identically.

Is Nevolat the same as Saxenda?
Yes. Nevolat contains the same active ingredient, liraglutide, at the same dose, just under a different brand name.

How much does Saxenda/generic liraglutide cost in the UK?
Historic Saxenda pricing ranged from roughly £46-£55 per pen depending on pack size. Current Nevolat pricing starts from around £94.97, though this varies by provider.

Can I get it on the NHS?
Generic liraglutide is available on the NHS for eligible patients, but requires a GP consultation to confirm eligibility first.

Final Thoughts

If you’re looking for Saxenda specifically, the most useful thing to know is that it isn’t currently available, and chasing a direct purchase is likely to lead you to an unreliable source. The practical path is the same medicine under its generic name, Nevolat, through a proper clinical consultation, or an alternative GLP-1 treatment if that suits you better.